<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03508388</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL18_0022</org_study_id>
    <nct_id>NCT03508388</nct_id>
  </id_info>
  <brief_title>Value on Survival of Liver Volume After an Acute Decompensation of an Alcoholic Cirrhosis</brief_title>
  <acronym>PROLIV</acronym>
  <official_title>Prognostic Value of Liver Volume on Acute Decompensation of Alcoholic Cirrhosis, a Prospective Multicenter Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Nīmes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Narbonne Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigator seek to determine whether the volume of the liver can predict the survival after
      a decompensation of a patient suffering from chronic liver disease caused by excessive
      alcohol consumption (or alcoholic cirrhosis). Our hypothesis is that patients with a &quot;small&quot;
      liver have a lower survival compared to patients having a &quot;normal&quot; sized liver.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this observational, prospective and multicentre clinical trial, investigator seek to
      determine the prognostic value of liver volume during an acute decompensation. Investigator
      plan to enroll admitted adult patients with acute decompensation of an alcoholic cirrhosis
      (abstinent or not), followed for one year or until death or liver transplantation. Liver
      volume will be evaluated using CT-scan or MRI reconstructions.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 25, 2018</start_date>
  <completion_date type="Anticipated">June 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality or liver transplantation</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Alcoholic Cirrhosis</condition>
  <condition>Alcoholic Liver Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients suffering from alcoholic cirrhosis, withdrawn or not, hospitalised for an
        acute decompensation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients

          -  Patient suffering from alcoholic cirrhosis (withdrawn or not)

          -  Patient admitted in emergency for an alcoholic cirrhosis decompensation only

          -  Prescription for a cutting imaging (CT scan or MRI) during hospitalisation

          -  Alcohol consumption of more than 3 units per day for men and 2 units for women in
             average, over at least the last 5 years before the cirrhosis diagnosis

          -  Patient suffering from decompensated cirrhosis defined by at least one of the
             following criteria : Model For End-Stage Liver Disease (MELD) score above or equal to
             15, ascites needing iterative punctures, symptomatic bacterial ou fungal infections,
             acute digestive bleeding due to portal hypertension, hepatic encephalopathy defined by
             a West Haven score above or equal to 2

        Exclusion Criteria:

          -  Nodule with typical criteria of hepatocellular carcinoma

          -  B or C viral infections actives

          -  Presence of transjugular intrahepatic portosystemic shunt (TIPS)

          -  Presence of an occlusive thrombosis of the porta or one of the principal branches

          -  Presence of a thrombosis of the sus-hepatic vein

          -  Active extra-hepatic malignant tumor

          -  Decompensated cardio-vascular disease

          -  Patient unwilling to participate to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose URSIC BEDOYA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UH Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jose URSIC BEDOYA, MD</last_name>
    <phone>0467337390</phone>
    <email>j-ursicbedoya@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Montpellier University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José URSIC BEDOYA, M.D.</last_name>
      <phone>+33-467337390</phone>
      <email>j-ursicbedoya@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>José URSIC BEDOYA, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Magdalena MESZAROS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ludovic CAILLO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 23, 2018</study_first_submitted>
  <study_first_submitted_qc>April 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Liver volume</keyword>
  <keyword>Alcoholic cirrhosis</keyword>
  <keyword>Liver transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Liver Diseases, Alcoholic</mesh_term>
    <mesh_term>Liver Cirrhosis, Alcoholic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

